Agio Pharmaceuticals is a finished-dose manufacturer based in India. It appears in 87 regulatory filings across 11 regulators, without an active US DMF or CEP on file. Its filings concentrate with UZPHARM (UZ), DIGEMAPS (DO) and RAMA (GE). Its GMP standing is certified by CDSCO (India), UZPHARM (UZ) and FDA (GH). Customs aggregates show $25.9M of exports covering 1,204 molecules to 25 destinations in 2025.
| Site | FDA FEI |
|---|---|
| Surendranagar, United Arab Emirates | Not on file |
| Pune, United Arab Emirates | Not on file |
| G.I.D.C., India | Not on file |
| surendranagar, India | Not on file |
| vapivapi 396 195valsad, India | Not on file |
| japur highwaydedhrota 383 220sabarkantha, India | Not on file |
| Regulator | Filings | GMP certificates |
|---|---|---|
| UZPHARM (UZ) | 49 | 1 |
| DIGEMAPS (DO) | 8 | None |
| RAMA (GE) | 7 | None |
| MINSA (CR) | 6 | None |
| EDE (AE) | 6 | None |
| US FDA | 4 | None |
| CDSCO (India) | None | 5 |
| FDA (GH) | None | 1 |
| Year | Revenue | Exports | Destinations |
|---|---|---|---|
| 2026 YTD | Not reported | $5.5M | 11 |
| 2025 | Not reported | $25.9M | 25 |
| 2024 | Not reported | $24.3M | 23 |
| 2023 | Not reported | $24.2M | 20 |
Export figures are customs aggregates. We do not publish the identity of any buyer.
Choose your molecules and target markets. Agio Pharmaceuticals comes back tiered against every other supplier able to file there.
Start for free